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Asbestos 
Clinical Screening Guidelines for Asbestos-Related 
Lung Disease 
Introduction A physician with expertise in the evaluation and management of asbestos-related lung 
diseases should screen patients who are now or have been in the past: 
• 	Workers involved in: 
– 	 Mining of asbestos or minerals contaminated with asbestos 
– 	 Manufacturing or using asbestos-containing products 
– 	 Custodial, maintenance and repair work in asbestos-containing buildings, or 
– 	 Direct contact with asbestos-containing waste or dust emissions 
• 	People: 
– 	Living in the vicinity of asbestos mines and asbestos-related industries such as a 
vermiculite processing plant 
– 	 In direct contact with asbestos-containing waste or dust emissions 
Medical history The medical history interview should include: 
• 	Reason for visit 
• 	Past medical history 
– 	Include general respiratory, tuberculosis, lung infection and cardiac history, 
rib fracture, thoracic surgery 
• 	Current respiratory health history 
– 	Progressive dyspnea on exertion, dry cough, fatigue, weight loss, tachypnea 
at rest 
• 	Smoking history 
– Include history of past attempts and/or willingness to quit, need for intervention 






Continued from previous page 
Medical history • General asbestos exposure history 
(continued) – Any direct contact with asbestos 
– Source, intensity, and duration of exposure 
– Age at first exposure and years since fi rst exposure 
• 	Occupational exposure history 
– 	 Asbestos and other chemical exposures on the job or from hobbies 
– 	High-risk occupations such as construction, demolition, remodeling, mining, and 
shipbuilding 
– 	 Source, intensity, and duration of exposure 




The physical exam should include: 
• 	Auscultation of heart and lungs 
• 	End-inspiratory basilar rales 
• 	Abdominal examination 
• 	Extremity examination (including clubbing, pulses, peripheral edema, and cyanosis) 
PA chest 
radiograph 
Note that radiological evidence is typically not present until at least 5 years after fi rst 
exposure. In addition to a clinical evaluation, the use of a B-Reader is recommended for 
radiographic rating of lung changes. The radiograph reader should look for: 
• 	Pleural changes 
– 	 Thickening and possible calcification of the parietal and visceral lung pleura 
– 	 Benign pleural effusion 
• 	Interstitial changes 
– 	 Small, irregular opacities in lower lung fields, “ground glass” appearance 
– 	Diffuse, bilateral interstitial fi brosis 
• 	Lung carcinoma/pulmonary nodules 
Simple pulmonary • Include FVC, FEV1, and FEV1/FVC ratio. 
function test (PFT • Asbestosis and some diffuse pleural disease may be characterized by restrictive 
or spirometry) changes. Among smokers, a mixed pattern may be noticed. 
• 	Consider pre- and post-bronchodilator, especially if obstructive component is evident. 
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Criteria for further • If x-ray is normal or inconclusive and exposure history is positive, repeat x-ray in 
evaluation subsequent years as needed. Lateral and/or oblique view recommended for incon­
clusive pleural changes. 
• 	Consider referring patients with possible restrictive lung disease, signifi cant radio­
graphic or pulmonary function abnormalities, or those with uncertain signifi cance, to 
a pulmonary specialist for complete pulmonary function tests and further evaluation. 
• 	CT scan: NOT a screening tool; recommended only if exam/PFT results suggest dis­
ease but x-ray does not correlate or if findings of uncertain significance are found on 
chest x-ray. 
• 	CT may assist in differentiating pleural plaques from soft-tissue densities, cancer ver­
sus rounded atelectasis. 
Some of the information is from the Minnesota Department of Health’s Clinical Screening 
Guidelines for Asbestos-Related Lung Disease 
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